TABLE 1.
Patient and Lesion Characteristics
| Characteristic | Value |
|---|---|
|
| |
| Sex | |
| Male | 25 (45.5) |
| Female | 30 (54.5) |
| Age, y | 68.3 ± 9.4 |
| Pack-years | 33.7 ± 32.9 |
| Hours between infusion and imaging | 14.6 ± 9.5 |
| Lesion characteristics | |
| PET SUV | 3.4 ± 2.6 |
| Lesion size, cm | 1.7 ± 0.8 |
| Lesion depth on imaging, cm | 0.5 ± 0.7 |
| Consolidation-to-tumor ratio | 0.52 ± 0.08 |
| Palpable ex vivo | 41 (74.5) |
| Location | |
| RUL | 16 (29.0) |
| RML | 3 (5.4) |
| RLL | 14 (25.5) |
| LUL | 14 (25.5) |
| LLL | 8 (14.5) |
| Final pathology | |
| Benign | 2 (3.6) |
| Non-small cell carcinoma | 41 (74.5) |
| Adenocarcinoma | 36 (65.5) |
| Adenocarcinoma in situ | 1 (1.8) |
| Squamous cell carcinoma | 4 (7.3) |
| Small cell carcinoma | 3 (5.5) |
| Metastasis | 5 (9.1) |
| Other | 4 (7.3) |
| Tumor differentiation | |
| Well | 6 (10.9) |
| Moderate | 24 (43.6) |
| Poor | 14 (25.5) |
| Not reported | 11 (20.0) |
| Operation performed | |
| Wedge resection | 11 (20.0) |
| Segmentectomy | 8 (14.5) |
| Lobectomy | 36 (65.5) |
Values are n (%) or mean ± SD. LLL, left lower lobe; LUL, left upper lobe; PET, positron emission tomography; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; SUV, standardized uptake value.